Pfizer Inc. pulled off a comeback win, beating out Danish drug giant Novo Nordisk to acquire obesity drug developer Metsera Inc. in a deal that values the biotechnology company at up to $9.1 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback